PhRMA Jumps Into Battle Over Mifepristone Regulation With Supreme Court Filing
Executive Summary
After sitting out the initial rounds, trade group backs FDA’s decisions on the medication abortion pill and asks Supreme Court to stay Texas district court ruling suspending the drug’s approval.
You may also be interested in...
Mifepristone Supporters Highlight Voter Trust In FDA Decisions Ahead Of Supreme Court Arguments
New poll from advocates pushing for courts and the states to stay out of FDA’s scientific decisions indicates majority of US voters support FDA drug safety determinations across party lines, though Republican support is more tentative.
GenBioPro Sues FDA To Keep Generic Mifepristone Available; Supreme Court Delays Its Decision
GenBioPro asks Maryland district court to prevent FDA from taking enforcement actions against it if Supreme Court allows stay of approval of mifepristone. Justice Samuel Alito extends deadline to respond until midnight Friday.
US FDA’s Califf Responds To, And Deflects, Senators’ Mifepristone Questions
The Senate Appropriations Subcommittee hearing was called to discuss the agency’s FY 2024 budget request, but several committee members wanted to talk about the pending Supreme Court decision on the medication abortion drug.